Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H22Cl2N2O |
| Molecular Weight | 329.265 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)N([C@@H]1CCC[C@H]1N(C)C)C2=CC=C(Cl)C(Cl)=C2
InChI
InChIKey=YCRFSKUCDBJWLX-HUUCEWRRSA-N
InChI=1S/C16H22Cl2N2O/c1-4-16(21)20(11-8-9-12(17)13(18)10-11)15-7-5-6-14(15)19(2)3/h8-10,14-15H,4-7H2,1-3H3/t14-,15-/m1/s1
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7328583
Curator's Comment: Eclanamine is CNS active in animals. No human data available,
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Dose-dependent down-regulation of beta-adrenergic receptors after chronic intravenous infusion of antidepressants. | 1988 |
|
| A new nontricyclic antidepressant agent. Synthesis and activity of N-[trans-2-(dimethylamino)cyclopentyl]-N-(3,4-dichlorophenyl)propanamide and related compounds. | 1981-10 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2851860
female Sprague-Dawley rats: 1, 3, 10, and 30 mg/kg/day
Route of Administration:
Intravenous
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CDC |
U-48753E
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
||
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5Y67H9W4KQ
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
PRIMARY | |||
|
5920
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
PRIMARY | |||
|
130380
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
PRIMARY | |||
|
CHEMBL20679
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
PRIMARY | |||
|
C81480
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
PRIMARY | |||
|
100000080487
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
PRIMARY | |||
|
71027-13-9
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
SUPERSEDED | |||
|
C057319
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
PRIMARY | |||
|
SUB06447MIG
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
PRIMARY | |||
|
67450-44-6
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
PRIMARY | |||
|
DTXSID001024475
Created by
admin on Mon Mar 31 17:59:09 GMT 2025 , Edited by admin on Mon Mar 31 17:59:09 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)